Publications by authors named "Beverly Ingram"

Claim this Profile
B
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
Eduardo Mysler, Valderilio Feijó Azevedo, Silvio Danese, Daniel Alvarez, Noriko Iikuni, Beverly Ingram

Drugs· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the Regulatory Science Applied to a Single Portfolio of Eight Biosimilar Product Approvals by Four Key Regulatory Authorities.
Beverly Ingram, Rebecca S Lumsden, Adriana Radosavljevic, Christine Kobryn

Pharmaceuticals (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key considerations in the preclinical development of biosimilars.
Lynne A Bui, Susan Hurst, Gregory L Finch, Beverly Ingram, Ira A Jacobs

Drug Discov Today· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis